Application no. and date | 02779711.7 (espacenet) (Federated) (European Patent Register), 20021121 | Patent/reg. no. and date | DK/EP 1448559, 20061227 | Publication date | 20040825 | Priority no. and date | GB 0127934, 20011121, GB 0127937, 20011121, GB 0127936, 20011121, GB 0127935, 20011121 | EP pub. no. and date |
EP 1448559 20040825 | Effective date | | Applicant/owner | SMITHKLINE BEECHAM PLC, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | P80700904DK00E | Inventor | Craig, Andrew, Simon, GlaxoSmithKline
Old Powder Mills
Near Leigh
Tonbridge, Kent TN11 9AN, GB, Millan, Michael, John, GlaxoSmithKline
Old Powder Mills
Near Leigh
Tonbridge, Kent TN11 9AN, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61P 5/48 (2006.01) , C07D 417/12 (2006.01) | Title | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel | Int. application no. | GB2002005232 | Int. publication no. | WO2003045946 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|